Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor
Atorvastatin and ticagrelor combination is a widely accepted therapy for secondary prevention of ischaemic heart disease. However, rhabdomyolysis is a well-known rare side effect of statins which should be considered when treatments are combined with cytochrome P450 3A4 enzyme inhibitors. We report...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Case Reports in Critical Care |
| Online Access: | http://dx.doi.org/10.1155/2017/3801819 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849399031626727424 |
|---|---|
| author | Iouri Banakh Kavi Haji Ross Kung Sachin Gupta Ravindranath Tiruvoipati |
| author_facet | Iouri Banakh Kavi Haji Ross Kung Sachin Gupta Ravindranath Tiruvoipati |
| author_sort | Iouri Banakh |
| collection | DOAJ |
| description | Atorvastatin and ticagrelor combination is a widely accepted therapy for secondary prevention of ischaemic heart disease. However, rhabdomyolysis is a well-known rare side effect of statins which should be considered when treatments are combined with cytochrome P450 3A4 enzyme inhibitors. We report a case of atorvastatin and ticagrelor associated severe rhabdomyolysis that progressed to multiorgan failure requiring renal replacement therapy, inotropes, intubation, and mechanical ventilation. Despite withdrawal of the precipitating cause and the supportive measures including renal replacement therapy, creatinine kinase increased due to ongoing rhabdomyolysis rapidly progressing to upper and lower limbs weakness. A muscle biopsy was performed to exclude myositis which confirmed extensive myonecrosis, consistent with statin associated rhabdomyolysis. After a prolonged ventilatory course in the intensive care unit, patient’s condition improved with recovery from renal and liver dysfunction. The patient slowly regained her upper and lower limb function; she was successfully weaned off the ventilator and was discharged for rehabilitation. To our knowledge, this is a second case of statin associated rhabdomyolysis due to interaction between atorvastatin and ticagrelor. However, our case differed in that the patient was also on amlodipine, which is considered to be a weak cytochrome P450 3A4 inhibitor and may have further potentiated myotoxicity. |
| format | Article |
| id | doaj-art-9db7d7917f9f48e7a2daa75c8fbfa0ef |
| institution | Kabale University |
| issn | 2090-6420 2090-6439 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Critical Care |
| spelling | doaj-art-9db7d7917f9f48e7a2daa75c8fbfa0ef2025-08-20T03:38:26ZengWileyCase Reports in Critical Care2090-64202090-64392017-01-01201710.1155/2017/38018193801819Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and TicagrelorIouri Banakh0Kavi Haji1Ross Kung2Sachin Gupta3Ravindranath Tiruvoipati4Department of Pharmacy, Frankston Hospital, Peninsula Health, Frankston, VIC 3199, AustraliaDepartment of Intensive Care Medicine, Frankston Hospital, Peninsula Health, Frankston, VIC 3199, AustraliaDepartment of Intensive Care Medicine, Frankston Hospital, Peninsula Health, Frankston, VIC 3199, AustraliaDepartment of Intensive Care Medicine, Frankston Hospital, Peninsula Health, Frankston, VIC 3199, AustraliaDepartment of Intensive Care Medicine, Frankston Hospital, Peninsula Health, Frankston, VIC 3199, AustraliaAtorvastatin and ticagrelor combination is a widely accepted therapy for secondary prevention of ischaemic heart disease. However, rhabdomyolysis is a well-known rare side effect of statins which should be considered when treatments are combined with cytochrome P450 3A4 enzyme inhibitors. We report a case of atorvastatin and ticagrelor associated severe rhabdomyolysis that progressed to multiorgan failure requiring renal replacement therapy, inotropes, intubation, and mechanical ventilation. Despite withdrawal of the precipitating cause and the supportive measures including renal replacement therapy, creatinine kinase increased due to ongoing rhabdomyolysis rapidly progressing to upper and lower limbs weakness. A muscle biopsy was performed to exclude myositis which confirmed extensive myonecrosis, consistent with statin associated rhabdomyolysis. After a prolonged ventilatory course in the intensive care unit, patient’s condition improved with recovery from renal and liver dysfunction. The patient slowly regained her upper and lower limb function; she was successfully weaned off the ventilator and was discharged for rehabilitation. To our knowledge, this is a second case of statin associated rhabdomyolysis due to interaction between atorvastatin and ticagrelor. However, our case differed in that the patient was also on amlodipine, which is considered to be a weak cytochrome P450 3A4 inhibitor and may have further potentiated myotoxicity.http://dx.doi.org/10.1155/2017/3801819 |
| spellingShingle | Iouri Banakh Kavi Haji Ross Kung Sachin Gupta Ravindranath Tiruvoipati Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor Case Reports in Critical Care |
| title | Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor |
| title_full | Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor |
| title_fullStr | Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor |
| title_full_unstemmed | Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor |
| title_short | Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor |
| title_sort | severe rhabdomyolysis due to presumed drug interactions between atorvastatin with amlodipine and ticagrelor |
| url | http://dx.doi.org/10.1155/2017/3801819 |
| work_keys_str_mv | AT iouribanakh severerhabdomyolysisduetopresumeddruginteractionsbetweenatorvastatinwithamlodipineandticagrelor AT kavihaji severerhabdomyolysisduetopresumeddruginteractionsbetweenatorvastatinwithamlodipineandticagrelor AT rosskung severerhabdomyolysisduetopresumeddruginteractionsbetweenatorvastatinwithamlodipineandticagrelor AT sachingupta severerhabdomyolysisduetopresumeddruginteractionsbetweenatorvastatinwithamlodipineandticagrelor AT ravindranathtiruvoipati severerhabdomyolysisduetopresumeddruginteractionsbetweenatorvastatinwithamlodipineandticagrelor |